Premier Alternatives

Lykos Therapeutics

San Jose, CA · Founded 2014 · Privately Held (backing)

Provider of psychedelic medicines and therapies intended to help people heal and grow. Lykos Therapeutics is based in San Jose, CA and was founded in 2014. Its last reported valuation was $224 million in Jan 2024. It has raised $150 million.

Last reported valuation
$224.0M
Oct 2026
Priced at
—
Total raised
$150.0M
Last round
—

Lykos Therapeutics key facts

as of Oct 2026
  • Provider of psychedelic medicines and therapies intended to help people heal and grow.
  • Lykos Therapeutics is valued at approximately $224.0M as of Oct 2026 (last reported valuation).
  • It has raised $150.0M; the latest was Later Stage VC ($50.0M) in Aug 2025.
  • Notable investors include Impact Assets, True Ventures, KittyHawk, Solari Capital, Lauder Partners — 28 tracked in total.
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$224.0M

Lykos Therapeutics's last reported valuation, Jan 2024. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Lykos Therapeutics with a free account
  • ·The complete investor list: 28 names
  • ·Watch Lykos Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Lykos Therapeutics funding rounds

No rounds on record

No funding rounds for Lykos Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Lykos Therapeutics valuation

Lykos Therapeutics's last reported valuation was $224 million in Jan 2024. No priced round, secondary trade or fund mark has surfaced since.

Lykos Therapeutics investors

28 investors are on record for Lykos Therapeutics, including Impact Assets, True Ventures, KittyHawk and Solari Capital. By type, the record holds 5 venture capital firms, 2 family offices and 1 hedge fund.

About Lykos Therapeutics

Provider of psychedelic medicines and therapies intended to help people heal and grow. The company specializes in the research, development, and integration of psychedelic medicines and therapies into the healthcare system, applying evidence-based research to create investigational psychedelics to catalyze therapeutic approaches for mental health conditions, enabling adults with post-traumatic stress disorder (PTSD) to address unmet needs in the mental healthcare space.

Sector
Healthcare
HQ
San Jose, CA, United States
Founded
2014
Employees
89
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.